System Transmission

Top Signal

100#1 JOB

Activity

2192Ripe

+952 today

System

Live1m

Terminal Asset View

stockNASDAQ

TELO

$1.32-5.71%

Telomir Pharmaceuticals Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

37Overripe

Live Analysis Active

Company Mission

Telomir Pharmaceuticals researches and develops potential treatments for diseases related to aging by focusing on telomeres, which are protective caps on chromosomes. Their experimental drugs aim to address conditions that become more common as people get older. The company earns money through research funding and hopes to generate future revenue from successful drug development and partnerships.

TEL

Industry Context

The biotechnology industry focuses on developing treatments using biological systems. Companies in this space often work on cutting-edge research for serious diseases, with success depending on clinical trial results and regulatory approvals. The sector tends to see increased attention when new scientific approaches gain momentum.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

72Matrix

Market Momentum

53.4— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.7x— Normal Volume

Today's Change

-5.71%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing TELO across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:53 PM UTC

As-of 03-14-2026 18:38 UTC

Develops drugs that target aging-related diseases and makes money by selling these treatments through pharmaceutical partnerships.

Price has been coiling in a tight range for the past two weeks near recent highs, suggesting energy building for the next directional move.

Biotech sector showing increased interest in longevity research, which could benefit companies with novel approaches to age-related conditions.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...